Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1040320220290020077
Pediatric Infection & Vaccine
2022 Volume.29 No. 2 p.77 ~ p.83
Obesity Is a Related Factor With Severe COVID-19 Pneumonia in Children: A Case Series
Kim Dong-Joon

Song Eun-Hyang
Jeon Kyung-Nyeo
Park Su-Eun
Seo Ji-Hyun
Abstract
A small proportion of children with coronavirus disease 2019 (COVID-19) develop severe pneumonia. We reported the severe COVID-19 pneumonia in children aged <18 years with COVID-19 treated with remdesivir and dexamethasone from August 2021 to November 2021 by a retrospective review of their medical records. Eight children were included (5 males and 3 females). Their median age was 16 years (range: 9 to 17 years) and their median body mass index was 30.5 kg/m2 (range: 22.8?38.5 kg/m2). All patients had fever and dyspnea with hypoxia. Chest radiographic findings were variable and included diffuse or multifocal consolidation, nodules, and ground-glass opacities in the lungs. After receiving intravenous remdesivir and dexamethasone, 7 of the 8 children experienced an improvement in their symptoms within 2 days. In our case series, obesity was present in 6 out of 8 children with severe COVID-19 pneumonia.
KEYWORD
COVID-19, Pneumonia, Child, Obesity
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI)